Quantcast Synthetic Reverses Anemia In EPO-Resistant Kidney Patients - Congoo
 
 
Log In
Synthetic Reverses Anemia in EPO-Resistant Kidney Patients
Have an interest in this Story?
Sign Up for Real-Time email updates
MedPage Today  | November 05, 2009

Note that the new drug (Hematide) increased hemoglobin concentration in chronic kidney disease patients with anemia caused by an autoimmune reaction to synthetic erythropoietin. Note that the study was small and that further clinical trials will be necessary to confirm the safety and efficacy of the...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Mark Palmer Mark Palmer
Founder
Internet consultancies
Rama Sethu Ranga Nathan Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.